Immediate local and regional recurrence after the excision of a polypoid melanoma: Tumor dormancy or tumor activation?

Dermatologic Surgery

Volumn 29, Issue 6, 2003, Pages 664-667

  De Giorgi, Vincenzo ^a   Massi, Daniela ^a   Gerlini, Gianni ^a   Mannone, Francesca ^a   Quercioli, Elena ^a   Carli, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNITY; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TIME FACTORS;

EID: 0037778012     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29163.x     Document Type: Article

References (18)

1. Sun Y, Paschen A, Schadendorf D. Cell-based vaccination against melanoma-background, preliminary results, and perspective. J Mol Med 1999;77:593-608.
2. Yeung RS. Management of recurrent cutaneous melanoma. Curr Prob Cancer 1994;18:143-86.
3. Guba M, Cernaianu G, Koehl G, et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res 2001;61:5575-9.
4. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastasis: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53.
5. Luzzi K, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865-73.
6. Drixler TA, Rinkes ED, Van Vroonhoven TJ, et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 2000;60:1761-5.
7. McGovern VJ, Shaw HM, Milton GW. Prognostic significance of polypoid configuration in malignant melanoma. Histopathology 1983;7:663-72.
8. Beardmore GL. Primary cutaneous polypoidal non-stageable melanomas in Queensland. Aust J Dermatol 1977;18:73-6.
9. Van der Esch EP, Cascinelli N, Preda F, Morabito A, Bufalino R. Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer 1981;48:1668-73.
10. Manci E, Balch CM, Murad TM, Soong SJ. Polypoid melanoma, a virulent variant of the nodular growth pattern. Am J Clin Pathol 1981;75:810-5.
11. Plotnick H, Rachmaninoff N, Vanden Berg HJ. Polypoid melanoma: a virulent variant of nodular melanoma. J Am Acad Dermatol 1990;23:880-4.
12. Shaw HM, Thompson JF. Polypoid melanoma is not rare [letter]. Br J Dermatol 1996;135:333-4.
13. Robbins PF, Kawakami Y. Human tumor antigens recognized by T cells. Curr Opin Immunol 1996;8:628-36.
14. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
15. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
16. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
17. Pinsolle V, Ravaud A, Baudet J. Does surgery promote the development of metastasis in melanoma? Ann Chir Plast Esthet 2000;45:485-93.
18. Demicheli R. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin Cancer Biol 2001;11: 297-306.